F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Safeguard resident-identifiable information and/or maintain medical records on each resident that are in
accordance with accepted professional standards.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to maintain clinical records on each resident, in accordance
with accepted professional health information management standards and practices, that are complete and
accurately documented for 4 of 4 residents (Residents #1, #2, #4, and #7) whose records were reviewed for
blood glucose monitoring and insulin administration.The facility failed to ensure insulin administration via
insulin pump and blood sugar results were documented as ordered on the Medication Administration
Record, dated September 2025, for Residents #1, #2, #4, and #7. These failures could place residents at
risk for inaccurate clinical health records. The findings included: Record review of the facility list of diabetic
residents who received insulin, dated 09/30/25, revealed the names of four current residents. Two of the
residents had insulin pumps and the other two residents received insulin injections. Record review of
Resident #1's admission Record, dated 10/02/2025, revealed an [AGE] year-old female admitted to the
facility on [DATE]. Resident #1's diagnoses included type 1 diabetes mellitus (autoimmune disease which
results in little to no insulin production), type 2 diabetes mellitus (the body does not use insulin effectively
and results in high blood sugar levels), and presence of insulin pump. Record review of Resident #1's
Medication Administration Records, dated 9/01/2025-9/30/2025, revealed the following:- Order dated
7/19/2025 for Novolog Injection Solution 100 unit/ml (Insulin Aspart) 230 units in the afternoon every 3 days
for Insulin Pump related to diabetes mellitus with diabetic chronic kidney disease, scheduled for 1400 (2:00
PM) was not initialed by the nurse on 9/06/25 and 9/09/25.- Order dated 1/12/2025 to announce meal
intake into the Insulin Pump 5 minutes prior to eating meal and no later than 5 minutes after starting to eat.
Do not announce meal if more than 30 minutes after Resident #1 started eating related to type 1 diabetes
mellitus (autoimmune disease which results in little to no insulin production), scheduled 3 times daily was
not initialed by the nurse for 0725 (7:25 AM) on 9/04/25, 9/06/25, 9/09/25, 9/12/25; for 1155 (11:55 AM) on
9/06/25, 9/09/25, 9/12/25, and for 1655 (4:55 PM) on 9/06/25.- Order dated 1/08/2025 to check bbg before
meals tid by Insulin Pump three times a day related to diabetes mellitus with diabetic chronic kidney
disease scheduled for 0730 (7:30 AM), 1130 (11:30 AM), and 1630 (4:30 PM) was not initialed by the nurse
for 7:30 AM on 9/04/25; for 7:30 AM, 11:30 AM, 4:30 PM on 9/06/25 and 9/09/25; and for 7:30 AM and
11:30 AM on 9/12/25. Record review of Resident #2's admission Record, dated 10/02/2025, revealed a
[AGE] year-old female admitted to the facility on [DATE]. Resident #1's diagnoses included type 1 diabetes
mellitus (autoimmune disease which results in little to no insulin production) and type 2 diabetes mellitus
with hyperglycemia (the body does not use insulin effectively and results in high blood sugar levels - with a
result of high blood sugar levels). Record review of Resident #2's Medication Administration Records, dated
9/01/2025-9/30/2025, revealed the following:- Order dated 7/19/2025 for Ozempic (0.25 or 0.5 mg/dose)
subcutaneous solution pen-injector 2 mg/3 ml (Semaglutide) - Inject 1 mg subcutaneously in
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
455893
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
455893
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/18/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Grace Care Center of Henrietta
807 W Bois D Arc
Henrietta, TX 76365
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
the morning every Friday related to type 2 diabetes mellitus with hyperglycemia until 10/02/2025 weekly for
4 weeks, scheduled for 0700 (7:00 AM) was not initialed by the nurse on 9/12/2025.- Order dated
7/19/2025 for Ozempic (0.25 or 0.5 mg/dose) subcutaneous solution pen-injector 2 mg/3 ml (Semaglutide).
Inject 0.5 mg subcutaneously in the morning every Friday related to type 2 diabetes mellitus with
hyperglycemia until 9/11/2025 weekly for 4 weeks, scheduled for 0800 (8:00 AM) was not initialed by the
nurse on 9/04/2025.- Order dated 8/21/2025 to announce meal intake into the Insulin Pump 10 minutes
prior to eating meal and no later than 10 minutes after starting to eat, with meals related to type 2 diabetes
mellitus with hyperglycemia was not initialed by the nurse for 0800 (8:00 AM) on 9/04/25, 9/06/25, 9/12/25;
for 1200 (12:00 PM) on 9/06/25 and 9/12/25; and for 1700 (5:00 PM) on 9/06/25 and 9/09/25.- Order dated
8/27/2025 for blood sugars tid before meals and record before meals for hypoglycemia was not initialed by
the nurse for 0700 (7:00 AM) on 9/04/25, 9/06/25, and 9/12/25; for 1130 (11:30 AM) on 9/06/25 and
9/12/25; and for 1630 (4:30 PM) on 9/06/25 and 9/09/25. Record review of Resident #4's admission Record,
dated 10/02/2025, revealed a [AGE] year-old female admitted to the facility on [DATE]. The resident's
diagnoses included type 2 diabetes mellitus (the body does not use insulin effectively). Record review of
Resident #4's Medication Administration Records, dated 9/01/2025-9/30/2025, revealed the following:Order dated 4/16/2025 for Lantus SoloStar Subcutaneous Solution Pen-injector 100 unit/ml (Insulin
Glargine) - Inject 30 unit subcutaneously in the morning related to type 2 diabetes mellitus with chronic
kidney disease, scheduled for 0700 (7:00 AM) was not initialed by the nurse on 9/06/25, 9/09/25, and
9/12/25.- Order dated 2/03/2023 for fsbs check with sliding scale coverage before meals for fsbs related to
Type 2 diabetes mellitus with diabetic chronic kidney disease with sliding scale was not initialed by the
nurse and did not have blood sugar levels documented for 1130 (11:30 AM) on 9/06/25, 9/09/25, 9/12/25,
and 9/15/25; and for 1630 (4:30 PM) on 9/09/25 and 9/12/25.- Order dated 4/03/25 for Novolog FlexPen
Subcutaneous Solution Pen-injector 100 unit/ml (Insulin Aspart) - Inject as per sliding scale if:150 - 209 = 1
unit;210 - 269 = 2 unit;270 - 329 = 3 unit;330 - 389 = 4 unit;390 - 449 = 5 unit;Notify Dr. [name] of greater
than 375, Subcutaneously before meals and at bedtime for diabetes.The nurse did not document the blood
sugar levels, the amount of insulin units if administered, and initial for 0700 (7:00 AM) on 9/06/25, 9/09/25,
9/12/25; for 1130 (11:30 AM) on 9/06/25, 9/099/25, 9/12/25, 9/15/25; for 1630 (4:30 PM) on 9/06/25,
9/09/25, 9/12/25, 9/17/25; and for 2000 (8:00 PM) on 9/05/25, 9/12/25, and 9/23/25. Record review of
Resident #7's admission Record, dated 10/02/2025, revealed a [AGE] year-old female admitted to the
facility on [DATE]. The resident's diagnoses included type 2 diabetes mellitus (the body does not use insulin
effectively). Record review of Resident #7's Medication Administration Records, dated
9/01/2025-9/30/2025, revealed the following:- Order dated 10/04/2024 for fasting bbg every morning,
scheduled for 0600 (6:00 AM) related to type 2 diabetes mellitus, did not have a documented blood sugar
level and was not initialed by the nurse on 9/06/25 and 9/09/25.- Order dated 10/28/2024 for Toujeo
SoloStar Subcutaneous Solution Pen-injector 300 unit/ml (Insulin Gargline) - Inject 60 unit subcutaneously
in the morning related to Type 2 diabetes mellitus with diabetic neuropathy, scheduled for 0800 (8:00 AM),
did not have a documented blood sugar level and was not initialed by the nurse as administered on 9/06/25,
9/09/25, 9/12/25. In an interview on 9/30/25 at 4:48 PM, C.N.A. A stated she was also a medication aide.
She stated she worked the day shift (6 AM - 6 PM) on 9/12/25 and the nurse scheduled to work that day
called in. She stated RN D came to the facility the morning of 9/12/25. C.N.A. A stated she had given the
residents their medications and RN D would have given the insulin injections to two residents - Resident #4
and Resident #7. During an interview and record review on 9/30/25 at 5:10 PM, the DON reviewed the
eMARs for Resident #4 and Resident #7 and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
455893
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
455893
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/18/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Grace Care Center of Henrietta
807 W Bois D Arc
Henrietta, TX 76365
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
stated the nurse had not signed off that she had administered the insulin injections for Resident #4 or
Resident #7 on 9/12/25. The DON stated both residents had scheduled insulin orders for the morning. She
stated there was no way of knowing whether or not the nurse administered the insulin injections. The DON
stated the nurse may have done it and just not signed off on the eMAR. The DON stated she had started
employment in the facility on 9/23/2025 and did not know who had been scheduled to work prior to that
date, as a working nursing schedule had not been kept with documented staff changes. In an interview on
10/01/25 at 1:41 PM, Resident #7 stated she was a diabetic and received an insulin shot in the morning
and pills at bedtime. Resident #7 stated she had not missed any insulin injections in the morning. She
stated, They know I need it. Resident #7 remembered RN D and stated she had given her insulin shots in
the morning and thought she had given the shots twice (on 2 occasions). In an interview on 10/01/25 at
2:47 PM, LVN B stated she was employed in the facility on and off for 2 years and usually worked on the
day shift 6 AM - 6 PM. LVN B stated the night shift nurse did the fsbs for the residents with injectable insulin
- Resident #4 and Resident #7. She stated the morning of 9/12/2025 the night shift nurse should have done
the fsbs for the 2 residents by 6 AM and documented the results on the eMAR. LVN B stated the 2
residents with the insulin pumps (Residents #1 and #2) had their blood sugar checked by a continuous
glucose monitor later when served breakfast. She stated the nurse pressed the button for the meal and slid
the administer insulin option by touch screen. In an interview on 10/02/25 at 11:53 AM, RN C stated she
was employed with the facility since the end of July 2025. RN C stated the nurses checked the diabetic
residents' blood sugars before administering insulin injections. She stated sometimes the night nurse did it
and sometimes the day shift nurse did it. RN C stated Residents #1 and #2 had insulin pumps and the
continuous glucose monitor was tied into their insulin pumps and would read their blood sugars. RN C
stated the nurse took the meal trays to Residents #1 and #2. She stated the two residents received insulin
before each meal and at bedtime. RN C stated sometimes she checked Resident #7's sugar in the morning,
but other times went by the night shift nurse's reading of the resident's blood sugar. She stated Resident #7
received insulin only in the morning and her insulin was long acting. RN C stated she took Resident #4's
blood sugar before giving her insulin as she received sliding scale insulin at breakfast and dinner. In an
interview on 10/02/25 at 4:48 PM, the DON stated the expectation for the nurses was that they prepared
insulin and documented on the eMAR when insulin was administered just like any other medication. She
stated the fsbs results were documented on either the eTAR or eMAR. She stated a possible outcome from
not doing so could be elevated blood sugars. The DON stated the insulin pumps would release insulin
without the meal being selected but it would be released at a later time. Record review of the facility's Policy
and Procedure: Administration of Insulin Therapy, dated 7/01/2025, revealed the following specifications [in
part]: I. Policy StatementIt is the policy of (facility name) to administer insulin only upon a licensed
practitioner's order to maintain therapeutic blood glucose control. Due to the high-risk nature of insulin,
administration requires mandatory safety checks, adherence to proper technique, and compliance with
State regulations.II. PurposeTo ensure the safe, accurate, and timely administration of insulin, including
basal, prandial, and correctional (sliding scale) doses, to standardize protocols for glucose monitoring and
management of acute complications (hypoglycemia/hyperglycemia).III. ScopeThis policy applies to all
licensed nursing staff (RNs and LVNs), and to unlicensed personnel (CNAs/Medication Aides) only when
administration is specifically delegated by a Registered Nurse and is compliant with (state name) Board of
Nursing rules.1. Restriction: In a Skilled Nursing Facility, the administration of injectable medications
(including insulin) is typically performed by a licensed nurse.D. Monitoring, Storage, and Documentation.4.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
455893
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
455893
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/18/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Grace Care Center of Henrietta
807 W Bois D Arc
Henrietta, TX 76365
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Documentation: The administering nurse will document on the MAR:- Insulin Type, Dose, Injection Site,
Date, and Time.- BGM result and time immediately prior to insulin administration
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
455893
If continuation sheet
Page 4 of 4